Loading stock data…
Clover Health Investments (CLOV)
$4.29+0.03 (+0.82%)
Market ClosedLast close Sep 8
Clover Health Investments, Corp.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
Clover Health Investments, Corp. in the Healthcare sector is trading at $4.29 with a market capitalization of $2.6B. Wall Street consensus targets $5.17 (3 analysts), implying a +20.4% move over the next 12 months. The stock is currently 23% below its 52-week high of $5.59, remaining 36.2% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +20.4% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $749.19M↑ | $487.71M↓ | $496.65M↑ | $477.62M↑ | $462.33M |
| Gross Profit | $159.54M↑ | $74.21M↑ | $73.18M↓ | $99.63M↓ | $108.89M |
| Operating Income | $27.33M↑ | -$49.32M↓ | -$24.38M↓ | -$10.56M↓ | -$1.27M |
| Net Income | $27.33M↑ | -$49.32M↓ | -$24.38M↓ | -$10.58M↓ | -$1.27M |
Peer Comparison
JNJUNHPFE
Fundamentals
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant,...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$2.63B
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-16.78%
Volume
Today's trading volume
3.04M
Recent News
3 Penny Stocks Trading Up To 94% Below Fair Value
Global services sectors are still growing, and employment is holding up in many major economies, even as costs remain a concern. That mix of resilience and pressure keeps investors hunting for lower priced stocks that still have enough cash to fund their plans. This article highlights three cash backed penny stocks from our premium low price screener that aim to give you early stage exposure with fewer balance sheet red flags. The stocks in the list below are just a starting sample, and the...
Clover Health (CLOV) Turns Profitable As Medicare Membership Explodes
On August 5, Clover Health Investments Corp. (NASDAQ:CLOV) reported second-quarter 2026 results that turned a year-ago loss into real profit. GAAP net income came in at $28 million, a $39 million swing from the $10.6 million loss posted in the same quarter last year. Medicare Advantage membership climbed to 157,309, up 48% year over year, […]
Clover Health Stock Stands Out Among Financially Fit Penny Stocks
Germany’s 10 year bond yield is near levels last seen in 2011, which shows how firmly markets are pricing in higher-for-longer interest rates. Higher yields often pressure richly valued large caps. That shifts more attention toward Financially Fit Penny Stocks, where entry prices are lower and balance sheets play a larger role. This article highlights three stocks from the screener that combine penny stock pricing with a focus on financial health. The three Financially Fit Penny Stocks in...
1 of Wall Street’s Favorite Stocks to Own for Decades and 2 Facing Headwinds
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
1 Healthcare Stock to Target This Week and 2 Facing Headwinds
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from elevated demand, and their momentum is only rising as the industry has posted a 28.9% gain over the past six months, beating the S&P 500 by 18 percentage points.